EUVIMEDEUVIMED entdecken
Crossref

Amelioration of Guishao Yigong Decoction on Colorectal Cancer Through the Integration of 16S rRNA Sequencing and Fecal Metabolomics

Wenwen Zhou, Yuwen Fan, Xiaoxiao Zhang, Meijuan Liu, Shu Jiang iD, Erxin Shang, Jinao Duan

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Wenwen Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Colorectal Neoplasms, RNA, Ribosomal, 16S, Feces. Die Arbeit nennt 84 Literaturangaben. Gefördert von: Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guishao Yigong Decoction (GYD), a classical formula, has been used to treat colorectal cancer (CRC) in clinical practices. However, its mechanism is still unclear. Increasing evidence suggests that the gut microbiota may serve as a potential target for treating CRC. Therefore, this study aims to elucidate the amelioration and potential mechanism of GYD on CRC by comprehensively analyzing the metagenome of gut microbiota and fecal metabolome. The results indicated that GYD significantly reduced the number and size of adenomas in the mouse colon, decreased spleen index, alleviated mouse emaciation and rectal bleeding, and protected the colonic barrier. 16S rRNA gene sequencing analysis revealed that GYD could markedly improve the dysbiosis of gut microbiota in CRC mice, increasing the abundance of beneficial bacteria and decreasing the abundance of pathogenic bacteria. Furthermore, the disordered fecal metabolic profiling of CRC mice was notably reversed by GYD. Following GYD administration, metabolites such as thiamine pyrophosphate, 3‐methylpentanoic acid, and propanoic acid significantly increased, whereas 2‐hydroxy‐2‐methylpropanoic acid, levodopa, and stearic acid remarkably decreased. Correlation analysis further indicated a close relationship between differential gut microbiota and metabolites. In conclusion, the amelioration of GYD on CRC might involve the regulation of gut microbiota and its metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalColorectal NeoplasmsRNA, Ribosomal, 16SFecesGastrointestinal MicrobiomeDysbiosisMetabolomicsAnimalsMiceSequence Analysis, RNAThiamine PyrophosphatePentanesPropionatesLevodopaStearic AcidsMice, Inbred C57BLMale

Stichwörter der Autor:innen

Guishao Yigong Decoctioncolorectal cancerfecal metabolomicsgut microbiota

Substanzen

Drugs, Chinese HerbalRNA, Ribosomal, 16SThiamine Pyrophosphate3-methylpentanePentanespropionic acidPropionatesLevodopastearic acidStearic Acids

Autor:innen und Institutionen

  • Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, China.

ORCID-Profile: Shu Jiang

Förderung

  • Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization

Zitieren

APA

Zhou, W., Fan, Y., Zhang, X., Liu, M., Jiang, S., Shang, E., & Duan, J. (2025). Amelioration of Guishao Yigong Decoction on Colorectal Cancer Through the Integration of 16S rRNA Sequencing and Fecal Metabolomics. Biomedical Chromatography. https://doi.org/10.1002/bmc.70198

Vancouver

Zhou W, Fan Y, Zhang X, Liu M, Jiang S, Shang E, et al. Amelioration of Guishao Yigong Decoction on Colorectal Cancer Through the Integration of 16S rRNA Sequencing and Fecal Metabolomics. Biomedical Chromatography. 2025. doi:10.1002/bmc.70198

BibTeX
@article{Zhou2025,
  author = {Zhou, Wenwen and Fan, Yuwen and Zhang, Xiaoxiao and Liu, Meijuan and Jiang, Shu and Shang, Erxin and Duan, Jinao},
  title = {Amelioration of Guishao Yigong Decoction on Colorectal Cancer Through the Integration of 16S rRNA Sequencing and Fecal Metabolomics},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70198}
}
Kostenlos starten →